Search research articles
Contact Us
Filters
Showing results (11-20 of 113) with videos related to
Page
of 12
Sort By:
International Clinical Psychopharmacology
|
February 22, 2020
Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatment
Chiara Fabbri, Stuart Montgomery, Cathryn M Lewis, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
November 4, 2008
Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder
Stuart Montgomery, Krai Chatamra, Lynne Pauer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
October 1, 2013
Challenging sequential approach to treatment resistant depression: cost-utility analysis based on the Sequenced Treatment Alternatives to Relieve Depression (STAR(⁎)D) trial
Paolo Olgiati, Emanuele Bajo, Marco Bigelli, et al.
Pharmacoeconomics
|
May 18, 2005
Economic considerations in the prescribing of third-generation antidepressants
Stuart Montgomery, John J Doyle, Lee Stern, et al.
Journal of Affective Disorders
|
March 7, 2021
Evaluation of MADRS severity thresholds in patients with bipolar depression
Michael E Thase, Amanda Harrington, Joseph Calabrese, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 3, 2012
European Group for the Study of Resistant Depression (GSRD)--where have we gone so far: review of clinical and genetic findings
Alexandra Schosser, Alessandro Serretti, Daniel Souery, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
February 2, 2019
High occupational level is associated with poor response to the treatment of depression: A replication study
Laura Mandelli, Alessandro Serretti, Daniel Souery, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 24, 2016
High occupational level is associated with poor response to treatment of depression
Laura Mandelli, Alessandro Serretti, Daniel Souery, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 17, 2012
A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder
Eduard Vieta, Stuart Montgomery, Ahmad Hatim Sulaiman, et al.
Journal of Affective Disorders
|
March 19, 2013
Pooled analysis of sustained response rates for extended release quetiapine fumarate as monotherapy or adjunct to antidepressant therapy in patients with major depressive disorder
Eduard Vieta, Michael Bauer, Stuart Montgomery, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 113) with videos related to
Sort By:
Page
of 12
International Clinical Psychopharmacology
|
February 22, 2020
Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatment
Chiara Fabbri, Stuart Montgomery, Cathryn M Lewis, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
November 4, 2008
Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder
Stuart Montgomery, Krai Chatamra, Lynne Pauer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
October 1, 2013
Challenging sequential approach to treatment resistant depression: cost-utility analysis based on the Sequenced Treatment Alternatives to Relieve Depression (STAR(⁎)D) trial
Paolo Olgiati, Emanuele Bajo, Marco Bigelli, et al.
Pharmacoeconomics
|
May 18, 2005
Economic considerations in the prescribing of third-generation antidepressants
Stuart Montgomery, John J Doyle, Lee Stern, et al.
Journal of Affective Disorders
|
March 7, 2021
Evaluation of MADRS severity thresholds in patients with bipolar depression
Michael E Thase, Amanda Harrington, Joseph Calabrese, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 3, 2012
European Group for the Study of Resistant Depression (GSRD)--where have we gone so far: review of clinical and genetic findings
Alexandra Schosser, Alessandro Serretti, Daniel Souery, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
February 2, 2019
High occupational level is associated with poor response to the treatment of depression: A replication study
Laura Mandelli, Alessandro Serretti, Daniel Souery, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 24, 2016
High occupational level is associated with poor response to treatment of depression
Laura Mandelli, Alessandro Serretti, Daniel Souery, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 17, 2012
A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder
Eduard Vieta, Stuart Montgomery, Ahmad Hatim Sulaiman, et al.
Journal of Affective Disorders
|
March 19, 2013
Pooled analysis of sustained response rates for extended release quetiapine fumarate as monotherapy or adjunct to antidepressant therapy in patients with major depressive disorder
Eduard Vieta, Michael Bauer, Stuart Montgomery, et al.
Page
of 12